PGY2 Resident Dr. Kuhl discusses the availability of the new hepatitis treatment to prisoners in the latest Urgent Matters

November 7, 2016

Dr. Evan KuhlLast month, Health Affairs published new research on hepatitis C treatment in American prisons. Hepatitis C is a liver disease and the most common bloodborne pathogen in the United States, infecting approximately 1 percent of the general population.(1) Within the prison population, however, the prevalence of hepatitis C is higher: 17 percent. Prisoners are a key demographic to decrease the spread of hepatitis C, which is spread through IV drug abuse because approximately 20-55 percent of inmates have used IV drugs in the past.